[Assessment of Risk Factors for Atherosclerosis in Individuals of Different Categories of Cardiovascular Risk Using

M Y Zubareva1, P P Malyshev1, A A Ansheles1

  • 1National Medical Research Center of Cardiology, Moscow.

Kardiologiia
|April 14, 2021
PubMed

Insights

The Aterostop calculator revealed that many individuals face high cardiovascular disease (CVD) risk, with diabetes mellitus showing exponential increases. Lipid-lowering treatment effectiveness in reaching target low-density lipoprotein cholesterol (LDL-C) levels was inversely proportional to CVD risk.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Medical Informatics

Background:

  • Cardiovascular diseases (CVDs) remain a leading cause of mortality globally.
  • Effective risk assessment tools are crucial for timely intervention and prevention strategies.
  • The Aterostop calculator offers a novel approach to comprehensive CVD risk evaluation.

Purpose of the Study:

  • To evaluate the initial outcomes of utilizing the Aterostop calculator for assessing cardiovascular disease (CVD) risk.
  • To analyze major and additional risk factors in individuals with and without established atherosclerotic CVD.

Main Methods:

  • A cross-sectional study involving 460 participants (healthy and with diagnosed atherosclerotic CVD).
  • Utilized the Aterostop application, developed at the National Medical Research Center of Cardiology, Moscow.
  • Assessed risk factors including age, smoking, arterial hypertension, diabetes mellitus (DM), and lipid profiles.

Main Results:

  • 45.4% of participants fell into very high and extreme CVD risk categories.
  • Arterial hypertension and diabetes mellitus prevalence increased with higher risk categories, with DM showing exponential growth.
  • While lipid-lowering medication use was associated with lower LDL-C, achieving target LDL-C levels was significantly poorer in high-risk individuals (3.7% in extreme risk vs. 75% in low risk).

Conclusions:

  • The Aterostop calculator's findings align with existing data on the suboptimal effectiveness of primary and secondary prevention of atherosclerotic CVDs.
  • There is a critical need for enhanced physician-patient collaboration to improve CVD prevention outcomes.
  • The study highlights the importance of accurate risk stratification tools like Aterostop in clinical practice.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
98
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
600
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
319
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
197
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
141
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
448